Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Inspyr Therapeutics Inc (OTCQB:NSPX)

0.5173
Delayed Data
As of May 25
 0.00 / 0.00%
Today’s Change
0.30
Today|||52-Week Range
5.01
-5.95%
Year-to-Date
No recent news for Inspyr Therapeutics Inc.

Today’s Trading

Previous close0.52
Today’s openn.a.
Day’s range-- - --
Volume20
Average volume (3 months)7,053
Market cap$818.3K
Dividend yield--
Data as of 05/25/2017

Growth & Valuation

Earnings growth (last year)+50.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book--

Competitors

No competitors data available.

Financials

Last reporting dateMay 29, 2017
EPS forecast (this quarter)-$5.10
Annual revenue (last year)$0.00
Annual profit (last year)-$3.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, CAO &
Executive Director
Christopher P. Lowe
Chief Medical Officer &
Senior Vice President
Ronald L. Shazer
Corporate headquarters
Westlake Village, California

Forecasts